BRD4 and breast carcinoma: We observed a reduction in RAC1 and BRD4 expressions in combination treated cells in comparison to control cell lines treated with DMSO in MCF-7, MDA-MB-231, SKBR3 and JIMT-1 breast cancer cells (Fig. 6A).